Dysregulated IL-6 signaling significantly contributes to the pathogenesis of neurodegenerative diseases (AD, HD, and PD) by promoting neuroinflammation, exacerbating Aβ accumulation and tau pathology in AD, compromising BBB integrity, and impairing neuronal survival and synaptic plasticity. Here, IL6 is linked to neurodegenerative disease.